JP2013519692 二官能性キレート化剤

Settings

Stemming

Single Family Member

Include NPL

Feedback

Goto Application

Office

Japan

Application Number 2012553161

Application Date 18.02.2011

Publication Number 2013519692

Publication Date 30.05.2013

Grant Number 5856982

Grant Date 18.12.2015

Publication Kind B2

IPC

View more classifications

View less classifications

CPC

View less classifications

Applicants ノルディオン　（カナダ）　インク．

Inventors アダム　マイク
ボロス　エスター
フェレイラ　カラ　リー
オルヴィグ　クリス
プライス　エリック　ダブリュー．

Agents 廣田　雅紀
小澤　誠次
東海　裕作
▲高▼津　一也
堀内　真

Priority Data 61/306,256 19.02.2010 US
61/394,739 19.10.2010 US

Title

(JA) 二官能性キレート化剤

Abstract

(JA)

式（Ｉ）（式中、変数Ｒ^１、Ｒ^１、Ｑ^１、Ｑ^２及びＭは、本出願の記載中で定義されている通りである）の二官能性キレート化剤。上記キレート化剤の、安定金属又は放射性金属のイオンとの錯体；生物学的担体と共有結合している錯体のコンジュゲート；及び該コンジュゲートを含有する医薬組成物についても記載される。

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
D	HETEROCYCLIC COMPOUNDS
213	Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
02	having three double bonds between ring members or between ring members and non-ring members
04	having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
24	with substituted hydrocarbon radicals attached to ring carbon atoms
36	Radicals substituted by singly-bound nitrogen atoms
40	Acylated substituent nitrogen atom

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39	Medicinal preparations containing antigens or antibodies
395	Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06	Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
22	Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30	Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
42	Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
44	Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42107; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Processing

National Phase Entries

Authority File

Settings

Feedback

Goto Application

1. JP2013519692 - 二官能性キレート化剤

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
51	Preparations containing radioactive substances for use in therapy or testing in vivo
02	characterised by the carrier ; , i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
04	Organic compounds
0474	complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N₂S₂, N₃S, NS₃, N₄ chelating group
0478	complexes from non-cyclic ligands, e.g. EDTA, MAG3

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
51	Preparations containing radioactive substances for use in therapy or testing in vivo
02	characterised by the carrier ; , i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
04	Organic compounds
08	Peptides, e.g. proteins ; , carriers being peptides, polyamino acids, proteins
082	the peptide being a RGD-containing peptide

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
51	Preparations containing radioactive substances for use in therapy or testing in vivo
02	characterised by the carrier ; , i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
04	Organic compounds
08	Peptides, e.g. proteins ; , carriers being peptides, polyamino acids, proteins
088	conjugates with carriers being peptides, polyamino acids or proteins

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
51	Preparations containing radioactive substances for use in therapy or testing in vivo
02	characterised by the carrier ; , i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
04	Organic compounds
0474	complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N₂S₂, N₃S, NS₃, N₄ chelating group
0478	complexes from non-cyclic ligands, e.g. EDTA, MAG3